# US 2025/0375411 A1 · Method for treating sickle cell disease using quercetin-containing compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0375411 A1
- Document ID: US20250375411A1
- Status: Published application
- Kind: A1
- Application number: 19/308,885
- Filed: 2025-08-25
- Published: 2025-12-11
- Earliest claimed: 2021-07-16
- Assignees: Beth Israel Deaconess Medical Center, Inc.
- Applicants: Beth Israel Deaconess Medical Center, Inc.
- Inventors: Jeffrey I. ZWICKER; Bruce FURIE; Robert FLAUMENHAFT
- Web page: https://patentgrep.com/patent/US20250375411A1

## CPC

- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61K 31/455: Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 7/06: Antianaemics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed are compositions and methods for treating sickle cell disease. Also disclosed are methods of treating sickle cell disease comprising administering to a subject in need thereof an effective amount of isoquercetin, vitamin B3, vitamin C, and optionally folic acid and wherein the effective amount is sufficient to halt progression of one or more of the symptoms of sickle cell disease.

## Claims

### Claim 1

A method of treating sickle cell disease, the method comprising administering to a subject in need thereof an effective amount of isoquercetin, vitamin B3, and vitamin C.

### Claim 2 (depends on 1)

The method of claim 1, wherein the composition further comprises folic acid.

### Claim 3 (depends on 2)

The method of claim 2, wherein the composition includes about 1000 μg to about 3000 μg of folic acid.

### Claim 4 (depends on 1)

The method of claim 1, wherein the composition includes about 250 mg to about 2500 mg of isoquercetin.

### Claim 5 (depends on 1)

The method of claim 1, wherein the composition includes about 20 μg to about 3 g of Vitamin B3.

### Claim 6 (depends on 1)

The method of claim 1, wherein the composition includes about 200 μg to about 3 g of Vitamin C.

### Claim 7 (depends on 1)

The method of claim 1, wherein the effective amount is sufficient to halt progression of one or more of the symptoms of sickle cell disease.
